These innovative medications , Semaglutide , represent a groundbreaking advancement in addressing metabolic dysfunction and potentially related conditions . These drugs are categorized as GLP-1 receptor https://lewysvgex785462.thechapblog.com/40218357/tirzepatide-a-comprehensive-dive-into-glp-1-compounds